News

CCMB researchers culture novel coronavirus; research may help in drug testing and vaccine development

Virologists at CCMB have isolated infectious viruses from several isolates. The ability to culture the virus in lab enables CCMB to work towards vaccine development.

Jun 01, 2020

By : Team ABLE

Richcore Lifesciences develops key enzymes for Covid-19 test kits

Richcore developes Taq Polymerase and Reverse Transcriptase enzymes

Jun 01, 2020

By : Team ABLE

Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients

Nafamostat has been identified as a potential candidate for Covid-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany

Jun 01, 2020

By : Team ABLE

DBT sets up four COVID-19 Bio Banks for vaccine and treatment development

The role of bio-banks for COVID-19 samples would be development of a vaccine and treatments

Jun 01, 2020

By : Team ABLE

DST initiates COVID-19 India National Supermodel for monitoring infection transmission & aid decision-making by policymakers

DST has initiated this exercise to pool in expertise in the field and create one model for the entire country that will be subjected to rigorous tests required for evidence-based forecasting.

Jun 01, 2020

By : Team ABLE